ProMIS Neurosciences Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
CEO Neil Warma and CFO Daniel Geffken issued standard Sarbanes-Oxley Section 302 and 906 certifications on August 13, 2026 for the Q2 2026 10-Q (period ended June 30, 2026). The certifications affirm that financial statements fairly present the company's financial condition and that disclosure controls and internal controls over financial reporting are operating effectively. No material weaknesses, significant deficiencies, or fraud were disclosed.
Why this rating
Routine SOX certification boilerplate with no disclosed control deficiencies or fraud. Standard filing requirement, not a business-changing event.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.